Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, hepatitis C (HCV), human immunodeficiency virus (HIV) and other serious health conditions. AbbVie sells its products worldwide directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its owned distribution centers and public warehouses. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US. AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of... Research Beam Model: Research Beam Product ID: 1725768 250 USD New
AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile
 
 

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile

  • Category : Medical Devices
  • Published On : July   2017
  • Pages : 51
  • Publisher : GlobalData
 
 
 
Summary

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, hepatitis C (HCV), human immunodeficiency virus (HIV) and other serious health conditions. AbbVie sells its products worldwide directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its owned distribution centers and public warehouses. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AbbVie Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AbbVie Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Stem CentRx Raises more than USD100 Million in Financing Round 10
Partnerships 10
Enterome Enters into Co-Development Agreement with AbbVie 10
OraSure Terminates Co-Promotion Agreement with AbbVie for OraQuick 11
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 12
Debt Offering 13
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 13
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 14
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 16
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 18
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 20
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 22
AbbVie Inc - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 35
Financial Announcements 35
Apr 27, 2017: AbbVie Reports First-Quarter 2017 Financial Results 35
Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 37
Oct 28, 2016: AbbVie Reports Third-Quarter 2016 Financial Results 39
Jul 29, 2016: AbbVie Reports Second-Quarter 2016 Financial Results 41
Apr 28, 2016: AbbVie Reports First-Quarter 2016 Financial Results 43
Jan 29, 2016: Abbvie Reports Full-Year 2015 And Fourth-Quarter Financial Results 45
Corporate Communications 47
Jan 15, 2016: AbbVie appoints Esteban Plata, Vice President, Western Europe & Canada, replaces Pascale Richetta who retires from AbbVie 47
Product News 48
May 17, 2017: AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology Annual Meeting 48
Jun 03, 2016: AbbVie to Highlight its Innovative Pipeline to the Investment Community 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
List of Tables
AbbVie Inc, Medical Equipment, Key Facts, 2016 1
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AbbVie Inc, Deals By Market, 2011 to YTD 2017 8
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Stem CentRx Raises more than USD100 Million in Financing Round 10
Enterome Enters into Co-Development Agreement with AbbVie 10
OraSure Terminates Co-Promotion Agreement with AbbVie for OraQuick 11
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 12
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 13
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 14
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 16
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 18
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 20
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 22
AbbVie Inc, Key Competitors 24
AbbVie Inc, Key Employees 25
AbbVie Inc, Subsidiaries 26
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter